People who received a flu vaccination were 24% less likely to test positive for COVID-19. And those who did contract the disease had a less severe course when compared with people who didn’t get a flu shot, investigators say.
Overall seasonal flu activity has remained at lower-than-usual levels in the United States and globally.
Hospitalized influenza patients who were given oseltamivir soon after diagnosis were less likely to be readmitted within 30 days and had shorter lengths of stay than their peers.
Older adults often face persistent functional decline after being hospitalized with influenza. The findings highlight the need for prevention, investigators say.
November flu rates lower than in 2019, pharmacy giant says … NIH: Older women with common breast cancer may not require chemotherapy … Peripheral neuropathy linked to higher mortality risk … Alzheimer’s blood test predicts future cognitive decline in healthy adults … Men with COVID are 3 times more likely to need intensive care: worldwide…
The Food and Drug Administration has expanded the use of the antiviral drug Xofluza (baloxavir marboxil) for use in preventing influenza after exposure to an ill person.
A high-dose, trivalent influenza vaccine was no more effective at preventing heart- and lung-related death and hospitalization than a standard-dose quadrivalent vaccine, the researchers say.
At-a-glance PPE shortages by state and COVID-19 positivity graphic released: AHCA … Uncontrolled hypertension found in a third of stroke survivors … Older LGBTQ adults have high rates of multimorbidity, mental illness, U.S. study finds … Record low global influenza rate likely due to social distancing
When vaccination coverage increases by 10%, antibiotic use drops significantly in the elderly, researchers report.
Seasonal recurrence may require repeat social distancing measures. That’s no comfort for the 400 eldercare facilities now dealing with outbreaks.
